Neutral Sphingomyelinase Inhibition Alleviates LPS-Induced Microglia Activation and Neuroinflammation after Experimental Traumatic Brain Injury
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Neuroinflammation is one of the key secondary injury mechanisms triggered by traumatic brain injury (TBI). Microglial activation, a hallmark of brain neuroinflammation, plays a critical role in regulating immune responses after TBI and contributes to progressive neurodegeneration and neurologic deficits following brain trauma. Here we evaluated the role of neutral sphingomyelinase (nSMase) in microglial activation by examining the effects of the nSMase inhibitors altenusin and GW4869 in vitro (using BV2 microglia cells and primary microglia), as well as in a controlled cortical injury (CCI) model in adult male C57BL/6 mice. Pretreatment of altenusin or GW4869 prior to lipopolysaccharide (LPS) stimulation for 4 or 24 hours, significantly downregulated gene expression of the pro-inflammatory mediators TNF-α, IL-1β, IL-6, iNOS, and CCL2 in microglia and reduced the release of nitric oxide and TNF-α. These nSMase inhibitors also attenuated the release of microparticles and phosphorylation of p38 MAPK and ERK1/2. In addition, altenusin pretreatment also reduced the gene expression of multiple inflammatory markers associated with microglial activation after experimental TBI, including TNF-α, IL-1β, IL-6, iNOS, CCL2, CD68, NOX2, and p22phox. Overall, our data demonstrate that nSMase inhibitors attenuate multiple inflammatory pathways associated with microglial activation in vitro and after experimental TBI. Thus, nSMase inhibitors may represent promising therapeutics agents targeting neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · cited 1×
“The latter include activation of inflammatory cytokines, chemokines, and microRNAs (miRs) (Perry et al., 2010; Prinz and Priller, 2014).”
BackgroundMechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.
Montecalvo, A., Larregina, A. T., Shufesky, W. J., Beer Stolz, D., Sullivan, M. L. G., Karlsson, J. M., Baty, C. J., Gibson, G. A., Erdos, G., Wang, Z., et al. (2012) · Blood · doi:10.1182/blood-2011-02-338004 · Cited by 1,429 · cited 2×
“It has been demonstrated that miRNA-155 and -146a mediate cell-to-cell communication through exosomes/microvesicles (MV) and participate in target gene modulation in bone marrow-derived dendritic cells and cardiovascular disease (Montecalvo et al., 2012; Hulsmans and Holvoet, 2013).”
BackgroundMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 1×
“The latter include activation of inflammatory cytokines, chemokines, and microRNAs (miRs) (Perry et al., 2010; Prinz and Priller, 2014).”
BackgroundKaminska, B. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.08.017 · Cited by 1,285
Ponomarev, E. D., Veremeyko, T., Barteneva, N., Krichevsky, A. M., & Weiner, H. L. (2011) · Nature Medicine · doi:10.1038/nm.2266 · Cited by 787 · cited 1×
“…various neurologic conditions, including neuroinflammation (Guedes et al., 2013), neurodegeneration (Sabirzhanov et al., 2018), autoimmune diseases (Ponomarev et al., 2011), and central nervous system injury (Sabirzhanov et al., 2014). miR-155 and miR-146 are two well-characterized…”
BackgroundAcid sphingomyelinase activity triggers microparticle release from glial cells
Bianco, F., Perrotta, C., Novellino, L., Francolini, M., Riganti, L., Menna, E., Saglietti, L., Schuchman, E. H., Furlan, R., Clementi, E., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.45 · Cited by 615
Brites, D., & Fernandes, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00476 · Cited by 599 · cited 1×
“We and others previously showed that microglia can release EVs that further activate the neighboring microglia and propagate the neuroinflammatory responses in the injured brain (Brites and Fernandes, 2015; Kumar et al., 2017; Paolicelli et al., 2018; Yang et al., 2018).”
BackgroundWalker, D. G., & Lue, L.-F. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0139-9 · Cited by 562
Loane, D. J., Kumar, A., Stoica, B. A., Cabatbat, R., & Faden, A. I. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000021 · Cited by 498 · cited 5×
“NOX2 has been implicated in microglial-mediated neurotoxicity in TBI (Loane et al., 2014; Kumar et al., 2016), so we analyzed the gene expression of NOX2 and p22phox in the injured cortex.”
BackgroundInfluentialSelf-citationExosome secretion is a key pathway for clearance of pathological TDP-43
Iguchi, Y., Eid, L., Parent, M., Soucy, G., Bareil, C., Riku, Y., Kawai, K., Takagi, S., Yoshida, M., Katsuno, M., et al. (2016) · Brain · doi:10.1093/brain/aww237 · Cited by 360 · cited 2×
“A number of studies have also begun to examine the effects of nSMase inhibitors, such as altenusin andGW4869, on brain immune cell function and as potential anti-inflammatory agents (Iguchi et al., 2016; Chua et al., 2017; Dickens et al., 2017; Huang et al., 2018; Sobue et al., 2018).”
BackgroundTargeting mi R‐155 restores abnormal microglia and attenuates disease in SOD 1 mice
Butovsky, O., Jedrychowski, M. P., Cialic, R., Krasemann, S., Murugaiyan, G., Fanek, Z., Greco, D. J., Wu, P. M., Doykan, C. E., Kiner, O., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24304 · Cited by 358 · cited 1×
“miR-155 and miR-146 are two well-characterized pro-inflammatory miRs that are associated with microglial activation and regulate cytokine release, chemokine production, and oxidative stress (Cardoso et al., 2012; Saba et al., 2012, 2014; Guedes et al., 2014; Butovsky et al., 2015).”
BackgroundMicroglial/Macrophage Polarization Dynamics following Traumatic Brain Injury
Kumar, A., Alvarez-Croda, D.-M., Stoica, B. A., Faden, A. I., & Loane, D. J. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4268 · Cited by 339 · cited 2×
“Microglia are not only pro-inflammatory or neurotoxic but also produce anti-inflammatory cytokines, alternative activation markers, and neurotrophic factors that can have positive and beneficial functions in resolving inflammation (Loane and Kumar, 2016).”
BackgroundSelf-citationCardoso, A. L., Guedes, J. R., Pereira de Almeida, L., & Pedroso de Lima, M. C. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03514.x · Cited by 336 · cited 1×
“characterized pro-inflammatory miRs that are associated with microglial activation and regulate cytokine release, chemokine production, and oxidative stress (Cardoso et al., 2012; Saba et al., 2012, Saba et al., 2014; Guedes et al., 2014; Butovsky et al., 2015).”
BackgroundDickens, A. M., Tovar-y-Romo, L. B., Yoo, S.-W., Trout, A. L., Bae, M., Kanmogne, M., Megra, B., Williams, D. W., Witwer, K. W., Gacias, M., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aai7696 · Cited by 285
Fenn, A. M., Gensel, J. C., Huang, Y., Popovich, P. G., Lifshitz, J., & Godbout, J. P. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.014 · Cited by 283
Bachstetter, A. D., Xing, B., de Almeida, L., Dimayuga, E. R., Watterson, D. M., & Van Eldik, L. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-79 · Cited by 282 · cited 1×
“Both MAPKs and NF-kB play key roles in the regulation of transcriptional activity of pro-inflammatory genes in microglia (Kim and Choi, 2010; Bachstetter et al., 2011; KopitarJerala, 2015; Shih et al., 2015).”
BackgroundLee, J.-T., Xu, J., Lee, J.-M., Ku, G., Han, X., Yang, D.-I., Chen, S., & Hsu, C. Y. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307017 · Cited by 280
Kumar, A., Barrett, J. P., Alvarez-Croda, D.-M., Stoica, B. A., Faden, A. I., & Loane, D. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.158 · Cited by 213
Self-citationShieh, C., Heinrich, A., Serchov, T., van Calker, D., & Biber, K. (2014) · Glia · doi:10.1002/glia.22628 · Cited by 179
Guedes, J. R., Custódia, C. M., Silva, R. J., de Almeida, L. P., Pedroso de Lima, M. C., & Cardoso, A. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu348 · Cited by 170
Harrison, E. B., Hochfelder, C. G., Lamberty, B. G., Meays, B. M., Morsey, B. M., Kelso, M. L., Fox, H. S., & Yelamanchili, S. V. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12092 · Cited by 151
Saba, R., Gushue, S., Huzarewich, R. L. C. H., Manguiat, K., Medina, S., Robertson, C., & Booth, S. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030832 · Cited by 151 · cited 1×
“…et al., 2014). miR-155 and miR-146 are two well-characterized pro-inflammatory miRs that are associated with microglial activation and regulate cytokine release, chemokine production, and oxidative stress (Cardoso et al., 2012; Saba et al., 2012, 2014; Guedes et al., 2014; Butovsky et al., 2015).”
BackgroundIn vivo inhibition of miR-155 significantly alters post-stroke inflammatory response
Pena-Philippides, J. C., Caballero-Garrido, E., Lordkipanidze, T., & Roitbak, T. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0753-x · Cited by 112
Yin, H., Song, S., & Pan, X. (2017) · Journal of Inflammation · doi:10.1186/s12950-017-0162-7 · Cited by 53
Induction of miR-155 after Brain Injury Promotes Type 1 Interferon and has a Neuroprotective Effect
Harrison, E. B., Emanuel, K., Lamberty, B. G., Morsey, B. M., Li, M., Kelso, M. L., Yelamanchili, S. V., & Fox, H. S. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00228 · Cited by 48
Myeloid extracellular vesicles: messengers from the demented brain
Nigro, A., Colombo, F., Casella, G., Finardi, A., Verderio, C., & Furlan, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00017 · Cited by 26 · cited 1×
“Recent studies indicate that myeloid cells can release EVs/MP that spread inflammatory signals both in vitro and in vivo to alter neuronal functions (Harrison-Brown et al., 2016; Nigro et al., 2016; Beneventano et al., 2017; Kumar et al., 2017).”
Background
Cited by
Shao, F., Wang, X., Wu, H., Wu, Q., & Zhang, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.825086 · Cited by 250
Exploring Sphingolipid Implications in Neurodegeneration
Alessenko, A. V., & Albi, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00437 · Cited by 141
Astrocyte-derived extracellular vesicles: A double-edged sword in central nervous system disorders
Zhao, S., Sheng, S., Wang, Y., Ding, L., Xu, X., Xia, X., & Zheng, J. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.027 · Cited by 90
Bidirectional Brain-Systemic Interactions and Outcomes After TBI
Faden, A. I., Barrett, J. P., Stoica, B. A., & Henry, R. J. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.12.004 · Cited by 57
Self-citationYe, Z., Hu, J., Xu, H., Sun, B., Jin, Y., Zhang, Y., & Zhang, J. (2021) · Inflammation · doi:10.1007/s10753-020-01399-3 · Cited by 35
Metadata
- Authors
- Kumar, A., Henry, R. J., Stoica, B. A., Loane, D. J., Abulwerdi, G., Bhat, S. A., & Faden, A. I.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 368
- Issue
- 3
- Pages
- 338-352
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2904497118
- Cited by
- 61
- References
- 29
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.